Parallel Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$74.4K Buy
5,492
+3,523
+179% +$42.1K ﹤0.01% 1895
2026
Q1
$11.8K Sell
1,969
-6,259
-76% -$47.1K ﹤0.01% 2685
2025
Q4
$59K Sell
8,228
-7,786
-49% -$61.5K ﹤0.01% 1758
2025
Q3
$171K Buy
16,014
+3,020
+23% +$29.6K ﹤0.01% 1128
2025
Q2
$126K Sell
12,994
-6,041
-32% -$62.3K ﹤0.01% 1242
2025
Q1
$283K Buy
19,035
+306
+2% +$4.71K 0.01% 809
2024
Q4
$279K Buy
18,729
+4,468
+31% +$72.8K 0.01% 792
2024
Q3
$273K Sell
14,261
-438
-3% -$9.08K 0.01% 796
2024
Q2
$304K Sell
14,699
-426
-3% -$8.47K 0.01% 711
2024
Q1
$284K Buy
15,125
+426
+3% +$7.31K 0.01% 726
2023
Q4
$212K Buy
14,699
+11,316
+334% +$154K 0.01% 771
2023
Q3
$58.7K Sell
3,383
-27
-0.8% -$563 ﹤0.01% 1314
2023
Q2
$71K Buy
3,410
+500
+17% +$10.9K ﹤0.01% 1224
2023
Q1
$68.5K Sell
2,910
-653
-18% -$17.5K ﹤0.01% 1219
2022
Q4
$99.5K Buy
3,563
+1,267
+55% +$32.4K ﹤0.01% 988
2022
Q3
$54K Buy
2,296
+337
+17% +$10.2K ﹤0.01% 1228
2022
Q2
$66K Sell
1,959
-193
-9% -$6.76K ﹤0.01% 1128
2022
Q1
$77K Sell
2,152
-182
-8% -$6.22K ﹤0.01% 1090
2021
Q4
$71K Sell
2,334
-335
-13% -$10.9K ﹤0.01% 1152
2021
Q3
$88K Sell
2,669
-921
-26% -$29.5K ﹤0.01% 1034
2021
Q2
$109K Buy
+3,590
New +$118K ﹤0.01% 913

Other funds holding OGN

Parallel Advisors's OGN Position: Q2 2026 in Review

Parallel Advisors increased its Organon & Co (OGN) stake by 179% in Q2 2026, buying an estimated $42.1K and bringing the position to 5,492 shares worth $74.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1895.

Parallel Advisors first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $304K in Q2 2024. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Parallel Advisors held 5,492 shares of Organon & Co worth $74.4K as of Q2 2026.
  • Parallel Advisors bought 3,523 Organon & Co shares in Q2 2026, an estimated $42.1K.
  • Organon & Co made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #1895 holding.
  • Parallel Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • Parallel Advisors's Organon & Co position peaked at $304K in Q2 2024.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.